Beranda › Kanker Ovarium › Virginia › Arlington
Uji klinis Kanker Ovarium di Arlington, VA
46 studi untuk Kanker Ovarium mencari peserta di lokasi sekitar Arlington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
The Vanguard Study: Testing a New Way to Screen for Cancer
Menerima pesertaSukarelawan sehat diterima
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauhnya
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Menerima pesertaFase 2
- Inova Fairfax Hospital, Falls Church · 4 mi jauhnya
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Menerima pesertaFase 1/2
- Research Site, Fairfax · 11 mi jauhnya
A Study of PHST001 in Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology - Virginia, Fairfax · 11 mi jauhnya
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
- NEXT Virginia, Fairfax · 11 mi jauhnya
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Menerima pesertaFase 2
- Next Virginia /ID# 279684, Fairfax · 11 mi jauhnya
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Menerima pesertaFase 1
- Site 04, Fairfax · 11 mi jauhnya
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Menerima pesertaFase 1
- Next Virginia /ID# 278607, Fairfax · 11 mi jauhnya
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Menerima pesertaFase 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · 11 mi jauhnya
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Menerima pesertaFase 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
Study of AVZO-021 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi jauhnya
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Menerima pesertaFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Menerima pesertaFase 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · 11 mi jauhnya
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Menerima pesertaFase 1/2
- NEXT Oncology, Fairfax · 11 mi jauhnya
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Menerima pesertaFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Menerima pesertaFase 2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Menerima pesertaFase 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
- Next Oncology Virginia, Fairfax · 11 mi jauhnya
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Menerima pesertaFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Menerima pesertaFase 1
- NEXT Oncology, Fairfax · 11 mi jauhnya
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Menerima pesertaFase 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · 11 mi jauhnya
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Menerima pesertaFase 1
- Inova Schar Cancer Institute, Falls Church · 4 mi jauhnya
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Menerima pesertaFase 1
- Normunity Investigational Site, Fairfax · 11 mi jauhnya
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Menerima peserta
- Inova Fairfax Hospital, Falls Church · 4 mi jauhnya
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauhnya
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Clinical Trial Site, Fairfax · 11 mi jauhnya
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Menerima pesertaFase 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Menerima pesertaFase 2
- 522, Fairfax · 11 mi jauhnya
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi jauhnya
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Menerima pesertaFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Menerima pesertaFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- NEXT, Fairfax · 11 mi jauhnya
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Menerima pesertaFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Menerima pesertaFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology, Fairfax · 11 mi jauhnya
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Menerima pesertaFase 1
- Dren Investigational Site, Fairfax · 11 mi jauhnya
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Menerima pesertaFase 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Uji klinis Kanker Ovarium di kota lain
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
- Pittsburgh, PA30 studi
Studi lain di Arlington
- Kanker Paru Non-Sel Kecil104 studi
- Kanker Metastatik53 studi
- Kanker Kolorektal52 studi
- Kanker (semua jenis)48 studi
- Kanker Payudara47 studi
- Kanker Paru41 studi
- Kanker Endometrium39 studi
- Kanker Pankreas33 studi
- Karsinoma Sel Skuamosa Kepala dan Leher26 studi
- Kanker Paru Sel Kecil23 studi
- Kanker Lambung20 studi
- Kanker Payudara Triple-Negatif20 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.